Chikungunya is a mosquito borne infectious disease causing long term, debilitating, arthritis like symptoms and death in severe cases. Climate change has increased in the home range of the formerly tropical mosquito vector, it can now potentially be found as far north as New York, and as far south as Sydney.
With severe morbidity, outbreaks on the increase, and an extensive geographical distribution of the virus, a Chikungunya Vaccine is greatly needed.
Sementis’ is working on a preventative vaccine for Chikungunya, based upon its proprietary SCV Vector System.
Details of our SCV-chikungunya vaccine preclinical proof-of-concept studies can be found in the follow publication that can be downloaded from: